-
NewAmsterdam Pharma to Present at Guggenheimβs SMID Cap Biotech Conference
29 Jan 2025 13:00 GMT
… company developing oral, non-statin medicines for patients at risk … the Guggenheim SMID Cap Biotech Conference on Wednesday, … In multiple phase 3 trials, NewAmsterdam is investigating obicetrapib … fixed-dose combination with ezetimibe, as LDL-C lowering …
-
Solid Self-Microemulsifying Drug Delivery System for Improved Oral Bioavailability of Relugolix: Preparation and Evaluation
25 Jan 2025 15:12 GMT
… supersaturable self-emulsifying drug delivery systems. Pharmaceutics. 2020;12 … their cellular reduction. Biotechnol Annu Rev. 2005 … nanomedicines for synergistic treatment of ulcerative colitis. … -emulsifying systems of ezetimibe with enhanced bioavailability …
-
Antidiabetic Drugs Market Poised to Growth USD 166.4 Billion by 2032 with Thriving CAGR of 4.39%
16 Jan 2025 07:51 GMT
… Outlook
Oral
Injectable
Antidiabetic Drugs Market Treatment Type Outlook
Type … ;reports/retinoids-market
Ezetimibe Market: https:/… .wiseguyreports.com/reports/ezetimibe-market
π π πΆπππΎ π¦ππ π±πΎπππππ, accuracy, reliability, …
-
Pharmaceutical reimbursement totaled β©26 trillion in 2023, up 8.5%
16 Jan 2025 09:06 GMT
… analysis of 2023 spending on pharmaceutical reimbursement showed an 8.5 … trillion won.
By ingredient, ezetimibe + rosuvastatin combination drug for hyperlipidemia, the top … people can use the medicines they need for medical treatment in time, expand …
-
Pediatric Healthcare Market Growth Accelerating at 4.75% CAGR to 288.0 Billion USD by 2032 | Kaiser Permanente, Cigna
29 Jan 2025 02:00 GMT
… such as AI, robotics, and biotechnology. AI is enhancing diagnostics, … medicine promise new frontiers in treatment. Quantum computing holds potential for advancing drug … wiseguyreports.com/reports/ezetimibe-market
Actovegin Market :https:…
-
6 drugs now in shortage
10 Jan 2025 20:18 GMT
… shortages, according to drug supply databases from the FDA and the American … will face shortages in 2025.Β
Ezetimibe; Simvastin tablet: Merck has discontinued … Pharmaceuticals reported a continued shortage of several presentations of this ADHD medication …
-
Safety and efficacy of moderate-intensity statin with ezetimibe in elderly patients with atherosclerotic cardiovascular disease.
23 Dec 2024 05:23 GMT
Jung-Joon Cha
Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
Ju Hyeon Kim
Division of Cardiology, Department of Internal Medicine, Korea University Anam …
-
Hanmi Pharm seeks approval for triple-combination hypertension drug
24 Dec 2024 05:20 GMT
… in phase 3 clinical trials, the therapy is … dual-action dyslipidemia drug, Rosuzet (ezetimibe, rosuvastatin).
According … treatment trends.
Hanmi highlighted the results of its phase 3 clinical trial … better tolerability, reducing medication-switching rates and …
-
Retail prices of 65 new drug formulations, ceiling prices of 13 formulations notified
23 Dec 2024 13:23 GMT
… Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug … bacterial infections, and painkillers, whereas drugs with revised ceiling prices include … combination drugs (FCDs), including a combination of atorvastatin and ezetimibe tablets …
-
One Of The Safest Cholesterol Medications Still Has A Few Unwanted Side Effects
22 Dec 2024 16:30 GMT
… drugs like atorvastatin or rosuvastatin are safe for most people, although statins … ;re just starting a statin medication or your doctor has recently increased your … cause diarrhea or stomach pain. Ezetimibe could also affect your liver …